biote Corp. (BTMD) stock
Close on Nov 11, 2026Market cap $39.16MP/E –Yield –
biote Corp. saw revenue fall 8.6% to $178.91M over the twelve months to Sep 30, 2026. Operating income fell 71.5% to $8.97M, moving the operating margin from 16.1% to 5.0%. Free cash flow was $7.41M, down 78.5% from a year earlier. At the latest close the market valued the company at $39.16M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $39.16M
- P/E ratio
- –
- Price to sales
- 0.22
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 18.92%
Fundamentals
- Revenue
- $178.91M
- Net income
- -$1.93M
- EPS, diluted
- -$0.11
- Free cash flow
- $7.41M
- Book value per share
- -$2.38
- Diluted shares
- 27M
Trading
- Next earnings
- Mar 10, 2027 (estimated, during market hours)
- Previous close
- $1.08
- Open
- $1.08
- Day's range
- $1.08 – $1.12
- Volume
- 19,128
- Average volume (20 days)
- 95,354
- Index membership
- Russell 2000 (since Jun 2023)
- Beta (5 years)
- 0.51
- 52-week range
- $0.99 – $2.90
- RSI (14 days)
- 45.5
- Volatility (1 year)
- 76.2%
- Relative volume
- 0.10×
- WACC
- 5.2%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BTMD | S&P 500 | Difference | BTMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -5.2% | -2.4% | −2.8 pts | ||
| 3 months | -29.2% | -1.2% | −28.1 pts | ||
| Year to date | -58.1% | +12.3% | −70.4 pts | ||
| 1 year | -58.2% | +12.4% | −70.6 pts | ||
| 3 years | -75.9% | +78.8% | −154.7 pts | -37.8% | +21.4% |
| 5 years | -88.9% | +75.2% | −164.0 pts | -35.5% | +11.9% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases biote filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- Results
About biote
Medicinal Chemicals & Botanical Products
biote Corp. operates in the wellness and healthcare sector, developing and providing the Biote Method along with Biote-branded dietary supplements and convenience kits. The company provides training programs and methodology for medical clinics and practitioners, allowing prescribers to offer compounded bioidentical hormone pellets, supplements, and related procedures to their patients. In addition to delivering clinical training services and contract term services, the business supports the sale and distribution of dietary supplements, disposable trocars, and procedure-related supplies directly to partnered clinics and certified healthcare professionals.
Company profile, executives and historybiote stock: common questions
What is biote's stock price?
BTMD closed at $1.09 on Nov 11, 2026, up 0.93% on the day. Over the past 52 weeks it traded between $0.99 and $2.90.
What is biote's market cap?
biote was worth $39.16M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BTMD's P/E ratio?
biote lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.11), so it has no meaningful P/E ratio.
How much revenue does biote make?
biote reported revenue of $178.91M for the twelve months to Sep 30, 2026, down 8.6% from a year earlier.
Does biote pay a dividend?
No. biote has not paid a cash dividend over the last twelve months.
When does biote report earnings next?
biote is expected to report Q4 FY2026 results on Mar 10, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has BTMD stock performed over the past year?
Including dividends, BTMD returned -58.2% over the past year, against +12.4% for the S&P 500.
How many BTMD shares are sold short?
1M shares were sold short at the latest FINRA report, 3.05% of the float, or 10.2 days of average trading volume.
Who are biote's competitors?
Companies most similar to biote by business, industry and size include MTEX, NAII, FTLF, LFVN, GLAS.
See a number that looks wrong?